<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present middle and long-term results of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and procarbazine therapy of <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Of 45 patients, 20 were followed for 1-4 years (14 successful cases, 5 satisfactory results with regression of inflammatory signs but no functional improvement, 1 failure), 17 for 5-10 years (9 successes, 5 satisfactory results, 3 failures), and 8 for 11-16 years (2 successes, 2 satisfactory results, 4 failures) </plain></SENT>
<SENT sid="2" pm="."><plain>The high percentage of success (over 55%) could be attributed partly to the early <z:hpo ids='HP_0003674'>onset</z:hpo> of therapy and may be partly to the choice of drugs </plain></SENT>
</text></document>